Remove Access Remove Article Remove Clinical Trials Remove Data
article thumbnail

Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Cannabis Law Report

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

article thumbnail

Vice Article: Australians Can Get a Medicinal Cannabis Prescription for Pretty Much Anything

Cannabis Law Report

First academic study of national medicinal cannabis data. This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. The authors note, however, that the data doesn’t include patient outcomes. Read their full article at . 11 May 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK: David Hardstaff And John Binns Write For Open Access Government Exploring Shifting Sands In The UK CBD Industry

Cannabis Law Report

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. One potential consequence of the FSA’s drive to rein in the UK’s CBD industry is reduced access to the previously available wide range of products.

Access 52
article thumbnail

More than half of prescriptions for medicinal cannabis in Australia given in Queensland, study says

Cannabis Law Report

Data obtained through a freedom of information request to drugs regulator the Therapeutic Goods Administration (TGA) revealed the age of those prescribed the drugs, the reason for prescribing, and the state or territory where the prescription was made. We are aware of clinical trials in that space, but not strong evidence.”.

article thumbnail

Study on MDMA for Traumatic Brain Injury Boosted By $1.5M Donation

SpeedWeed

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”.

article thumbnail

Recent Study Suggests MMJ Cards Increase the Risk of CUD—But Is There More to It?

Veriheal

Kevin Potter taking responsibility for the integrity and accuracy of the data. a necessary question to address as medical marijuana becomes more accessible. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms.

article thumbnail

Radicle Science Launches Largest Longitudinal Real World Evidence Study to Determine Effectiveness of CBD Products

Cannabis Law Report

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105